森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/12/27 | 2,105 | 2,105 | 2,070 | 2,075 | +20 | +1% | 2,300 |
| 2024/12/26 | 2,063 | 2,063 | 2,052 | 2,055 | -5 | -0.2% | 3,300 |
| 2024/12/25 | 2,064 | 2,064 | 2,055 | 2,060 | -1 | ±0% | 4,000 |
| 2024/12/24 | 2,063 | 2,065 | 2,061 | 2,061 | -1 | ±0% | 1,700 |
| 2024/12/23 | 2,069 | 2,070 | 2,061 | 2,062 | -7 | -0.3% | 2,800 |
| 2024/12/20 | 2,066 | 2,069 | 2,060 | 2,069 | +4 | +0.2% | 4,400 |
| 2024/12/19 | 2,061 | 2,065 | 2,060 | 2,065 | +1 | ±0% | 1,400 |
| 2024/12/18 | 2,060 | 2,066 | 2,058 | 2,064 | -2 | -0.1% | 4,600 |
| 2024/12/17 | 2,062 | 2,073 | 2,059 | 2,066 | +4 | +0.2% | 2,200 |
| 2024/12/16 | 2,071 | 2,071 | 2,062 | 2,062 | -9 | -0.4% | 2,900 |
| 2024/12/13 | 2,071 | 2,074 | 2,070 | 2,071 | -3 | -0.1% | 1,500 |
| 2024/12/12 | 2,073 | 2,074 | 2,071 | 2,074 | -6 | -0.3% | 1,700 |
| 2024/12/11 | 2,074 | 2,081 | 2,074 | 2,080 | +5 | +0.2% | 1,700 |
| 2024/12/10 | 2,075 | 2,082 | 2,075 | 2,075 | -4 | -0.2% | 1,500 |
| 2024/12/09 | 2,079 | 2,079 | 2,075 | 2,079 | -2 | -0.1% | 1,100 |
| 2024/12/06 | 2,075 | 2,081 | 2,074 | 2,081 | +6 | +0.3% | 1,200 |
| 2024/12/05 | 2,080 | 2,081 | 2,074 | 2,075 | -5 | -0.2% | 1,800 |
| 2024/12/04 | 2,080 | 2,086 | 2,079 | 2,080 | -5 | -0.2% | 2,100 |
| 2024/12/03 | 2,096 | 2,099 | 2,083 | 2,085 | +2 | +0.1% | 3,400 |
| 2024/12/02 | 2,094 | 2,094 | 2,068 | 2,083 | +14 | +0.7% | 900 |
| 2024/11/29 | 2,090 | 2,097 | 2,067 | 2,069 | -25 | -1.2% | 1,500 |
| 2024/11/28 | 2,090 | 2,094 | 2,079 | 2,094 | +4 | +0.2% | 2,800 |
| 2024/11/27 | 2,092 | 2,092 | 2,085 | 2,090 | -2 | -0.1% | 1,100 |
| 2024/11/26 | 2,110 | 2,110 | 2,081 | 2,092 | -18 | -0.9% | 4,100 |
| 2024/11/25 | 2,119 | 2,119 | 2,110 | 2,110 | -4 | -0.2% | 1,200 |
| 2024/11/22 | 2,115 | 2,115 | 2,110 | 2,114 | +4 | +0.2% | 800 |
| 2024/11/21 | 2,111 | 2,111 | 2,110 | 2,110 | ±0 | ±0% | 400 |
| 2024/11/20 | 2,116 | 2,121 | 2,110 | 2,110 | -1 | ±0% | 700 |
| 2024/11/19 | 2,115 | 2,115 | 2,111 | 2,111 | ±0 | ±0% | 300 |
| 2024/11/18 | 2,114 | 2,114 | 2,110 | 2,111 | -3 | -0.1% | 700 |
| 2024/11/15 | 2,114 | 2,120 | 2,102 | 2,114 | ±0 | ±0% | 1,100 |
| 2024/11/14 | 2,103 | 2,115 | 2,102 | 2,114 | +11 | +0.5% | 1,800 |
| 2024/11/13 | 2,102 | 2,118 | 2,101 | 2,103 | -26 | -1.2% | 2,100 |
| 2024/11/12 | 2,113 | 2,138 | 2,103 | 2,129 | +24 | +1.1% | 5,800 |
| 2024/11/11 | 2,104 | 2,128 | 2,104 | 2,105 | +1 | ±0% | 900 |
| 2024/11/08 | 2,102 | 2,109 | 2,102 | 2,104 | +3 | +0.1% | 800 |
| 2024/11/07 | 2,105 | 2,105 | 2,101 | 2,101 | -16 | -0.8% | 2,000 |
| 2024/11/06 | 2,117 | 2,121 | 2,105 | 2,117 | +2 | +0.1% | 1,400 |
| 2024/11/05 | 2,138 | 2,138 | 2,101 | 2,115 | +13 | +0.6% | 1,500 |
| 2024/11/01 | 2,112 | 2,112 | 2,102 | 2,102 | -10 | -0.5% | 1,500 |
| 2024/10/31 | 2,115 | 2,115 | 2,110 | 2,112 | +1 | ±0% | 500 |
| 2024/10/30 | 2,108 | 2,126 | 2,108 | 2,111 | -14 | -0.7% | 1,400 |
| 2024/10/29 | 2,129 | 2,129 | 2,101 | 2,125 | -13 | -0.6% | 1,000 |
| 2024/10/28 | 2,097 | 2,138 | 2,097 | 2,138 | +37 | +1.8% | 500 |
| 2024/10/25 | 2,118 | 2,118 | 2,097 | 2,101 | -19 | -0.9% | 2,100 |
| 2024/10/24 | 2,105 | 2,120 | 2,101 | 2,120 | +13 | +0.6% | 1,400 |
| 2024/10/23 | 2,104 | 2,132 | 2,104 | 2,107 | +3 | +0.1% | 700 |
| 2024/10/22 | 2,110 | 2,134 | 2,102 | 2,104 | -5 | -0.2% | 2,000 |
| 2024/10/21 | 2,136 | 2,136 | 2,109 | 2,109 | -22 | -1% | 500 |
| 2024/10/18 | 2,107 | 2,131 | 2,103 | 2,131 | +24 | +1.1% | 1,000 |
101～
150
件表示中 / 3711件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 211,400円 | +0.3% | +9.2% | 3.07% | 12.01倍 | 0.71倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ＰＲＩＳＭＢｉｏ | 25,100円 | +14.8% | - | 0.00% | - | 3.01倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
| ＮＡＮＯ | 12,900円 | -30.6% | - | 0.00% | - | 3.34倍 |
|
ｍＲＮＡ医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
| ケイファーマ | 72,600円 | - | - | 0.00% | - | 3.73倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
| シンバイオ | 17,100円 | -24.2% | - | 0.00% | - | 2.15倍 |
|
導入で新薬開発・製品化。抗がん剤「トレアキシン」国内販売。抗ウイルス薬ＢＣＶの開発に注力 |
市場注目の銘柄
チャート関連のコラム
